Creative Planning - CYTOSORBENTS CORP ownership

CYTOSORBENTS CORP's ticker is CTSO and the CUSIP is 23283X206. A total of 74 filers reported holding CYTOSORBENTS CORP in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Creative Planning ownership history of CYTOSORBENTS CORP
ValueSharesWeighting
Q3 2023$40,035
-47.6%
21,2950.0%0.00%
Q2 2023$76,449
+6.5%
21,2950.0%0.00%
Q1 2023$71,764
+117.4%
21,2950.0%0.00%
Q4 2022$33,007
+13.8%
21,2950.0%0.00%
Q3 2022$29,000
-43.1%
21,295
-9.1%
0.00%
Q2 2022$51,000
-25.0%
23,415
+10.0%
0.00%
Q1 2022$68,000
-26.9%
21,295
-4.5%
0.00%
Q4 2021$93,000
-48.0%
22,295
+0.9%
0.00%
Q3 2021$179,000
+8.5%
22,095
+1.4%
0.00%
Q2 2021$165,000
-28.6%
21,795
-18.0%
0.00%
Q1 2021$231,000
+9.0%
26,5950.0%0.00%
Q4 2020$212,000
+0.5%
26,595
+0.8%
0.00%
-100.0%
Q3 2020$211,000
-38.7%
26,395
-24.0%
0.00%0.0%
Q2 2020$344,000
+39.3%
34,735
+8.7%
0.00%0.0%
Q1 2020$247,000
+87.1%
31,962
-6.7%
0.00%
Q4 2019$132,000
-23.7%
34,240
-0.4%
0.00%
-100.0%
Q3 2019$173,000
-23.8%
34,3900.0%0.00%0.0%
Q2 2019$227,000
-12.7%
34,3900.0%0.00%0.0%
Q1 2019$260,000
-5.5%
34,390
+0.9%
0.00%0.0%
Q4 2018$275,000
-37.6%
34,090
-32.5%
0.00%
-50.0%
Q3 2018$441,000
-29.9%
50,490
-31.9%
0.00%0.0%
Q2 2018$629,000
+2229.6%
74,090
+1095.0%
0.00%
Q2 2017$27,0000.0%6,200
+5.1%
0.00%
Q1 2017$27,000
-10.0%
5,900
+7.3%
0.00%
Q4 2016$30,000
-14.3%
5,5000.0%0.00%
Q3 2016$35,000
+40.0%
5,5000.0%0.00%
Q2 2016$25,000
+13.6%
5,5000.0%0.00%
Q1 2016$22,000
+633.3%
5,500
+1000.0%
0.00%
Q4 2015$3,0005000.00%
Other shareholders
CYTOSORBENTS CORP shareholders Q4 2019
NameSharesValueWeighting ↓
Skylands Capital, LLC 815,869$3,141,0000.46%
Sargent Investment Group, LLC 499,010$1,921,0000.36%
Anson Funds Management LP 74,440$287,0000.33%
One68 Global Capital, LLC 39,241$151,0000.33%
Granahan Investment Management 678,618$2,613,0000.12%
Winning Points Advisors, LLC 30,000$115,0000.07%
Avenir Corp 150,600$580,0000.06%
HighMark Wealth Management LLC 10,000$38,0000.04%
Wealthcare Advisory Partners LLC 62,279$240,0000.03%
GSA CAPITAL PARTNERS LLP 64,970$250,0000.03%
View complete list of CYTOSORBENTS CORP shareholders